Woo Chan Shin
Overview
Explore the profile of Woo Chan Shin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang H, Kim P, Eun J, Shen Q, Kim H, Shin W, et al.
Oncotarget
. 2016 Feb;
7(10):11412-23.
PMID: 26863632
H2A.Z is a highly conserved H2A variant, and two distinct H2A.Z isoforms, H2A.Z.1 and H2A.Z.2, have been identified as products of two non-allelic genes, H2AFZ and H2AFV. H2A.Z has been...
2.
Bae H, Jung K, Eun J, Shen Q, Kim H, Park S, et al.
J Hepatol
. 2015 Mar;
63(2):408-19.
PMID: 25817558
Background & Aims: Most common reason behind changes in histone deacetylase (HDAC) function is its overexpression in cancer. However, among HDACs in liver cancer, HDAC6 is uniquely endowed with a...
3.
Kim H, Lee K, Bae H, Eun J, Shen Q, Park S, et al.
Oncotarget
. 2015 Mar;
6(10):8089-102.
PMID: 25797269
MicroRNA-31 (miR-31) is among the most frequently altered microRNAs in human cancers and altered expression of miR-31 has been detected in a large variety of tumor types, but the functional...
4.
Eun J, Bae H, Shen Q, Park S, Kim H, Shin W, et al.
J Appl Toxicol
. 2014 Sep;
35(2):152-64.
PMID: 25231249
Drug-induced liver injury (DILI) is a major safety concern during drug development and remains one of the main reasons for withdrawal of drugs from the market. Although it is crucial...
5.
Park S, Kim J, Bae H, Eun J, Shen Q, Kim H, et al.
Cancer Lett
. 2014 Aug;
354(1):97-106.
PMID: 25111897
The aberrant regulation of histone deacetylase 6 (HDAC6) contributes to malignant progression in various types of cancer, but the mechanism underlying gastric carcinogenesis remains unknown. Aberrant HDAC6 overexpression was observed...
6.
Noh J, Bae H, Eun J, Shen Q, Park S, Kim H, et al.
Cancer Res
. 2014 Jan;
74(6):1728-38.
PMID: 24448241
Aberrant regulation of histone deacetylase 2 (HDAC2) contributes to malignant progression in various cancers, but the underlying mechanism leading to the activation of oncogenic HDAC2 remains unknown. In this study,...
7.
Shen Q, Bae H, Eun J, Kim H, Park S, Shin W, et al.
Cancer Lett
. 2013 Nov;
344(2):204-11.
PMID: 24189458
Nemo-like kinase (NLK), an evolutionarily conserved MAP kinase-related kinase, has been reported to be involved in the development of hepatocellular carcinoma (HCC), but the underlying mechanisms leading to oncogenic NLK...